Trademark: 88900007
Status Date
Tuesday, March 29, 2022
Registration Number
6688308
Registration Date
Tuesday, March 29, 2022
Filing Date
Monday, May 4, 2020
42 Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of computer platform technology, namely, development of cancer immunotherapy software platforms for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; Information technology platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; Electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials
The English translation of the word "ONCOLOGUES" in the mark is "ONCOLOGISTS".
Mar 29, 2022
Registered-Supplemental Register
Feb 22, 2022
Law Office Publication Review Completed
Feb 18, 2022
Assigned To Lie
Feb 14, 2022
Approved For Registration Supplemental Register
Feb 14, 2022
Examiner's Amendment Entered
Feb 14, 2022
Notification Of Examiners Amendment E-Mailed
Feb 14, 2022
Examiners Amendment E-Mailed
Feb 14, 2022
Examiners Amendment -Written
Feb 12, 2022
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Feb 11, 2022
Use Amendment Accepted
Jan 27, 2022
Teas/Email Correspondence Entered
Jan 27, 2022
Correspondence Received In Law Office
Jan 27, 2022
Teas Request For Reconsideration Received
Jan 27, 2022
Amendment To Use Processing Complete
Jan 27, 2022
Use Amendment Filed
Jan 26, 2022
Teas Amendment Of Use Received
Jul 28, 2021
Notification Of Final Refusal Emailed
Jul 28, 2021
Final Refusal E-Mailed
Jul 28, 2021
Final Refusal Written
Jun 21, 2021
Assigned To Examiner
Feb 3, 2021
Teas/Email Correspondence Entered
Feb 3, 2021
Correspondence Received In Law Office
Feb 3, 2021
Teas Response To Office Action Received
Aug 4, 2020
Notification Of Non-Final Action E-Mailed
Aug 4, 2020
Non-Final Action E-Mailed
Aug 4, 2020
Non-Final Action Written
Jul 29, 2020
Assigned To Examiner
May 15, 2020
New Application Office Supplied Data Entered In Tram
May 7, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
